Biological markers in primary and secondary lymphedema
Part of Blood & lymphatic clinical trials.
This study is looking at blood and skin samples from people with lymphedema to find markers that might explain the condition better. This could help improve diagnosis and treatment in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 45 years old
- Have lymphedema (primary or secondary) or be a healthy volunteer
- Be willing to give a blood sample and a skin swab
- Not smoke
- Not be pregnant or breastfeeding
- Not have an active infection or cellulitis in the last 4 weeks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects samples (like blood and possibly lymph fluid-related tests) to help doctors better tailor treatment for lymphedema. It may help researchers find ways to improve outcomes for people treated for swollen, fluid-rich tissue.
This study looks at lymphatic “drainage” problems (lymphedema) and how they develop after breast cancer treatment. It may help doctors better understand lymphedema and improve care for people who meet the study safety requirements.
This study looks at the bacteria in your gut and how they relate to lymphedema (swelling) and repeated skin infections in the affected limb. It compares people who have many infections with those who have none, to better understand why some get infections and others don't.
This study looks at a blood marker called Lp(a) in adults who have lymphedema. The goal is to understand whether checking Lp(a) is important for people with this condition.
This study uses special ultrasound techniques to help doctors tell the difference between lymphedema (fluid swelling) and lipedema (fat swelling) in the legs. If you have one of these conditions or have healthy legs, you may be able to join.
This study looks at skin lymphomas (a type of white blood cell cancer that starts in the skin) to find factors that predict how the disease will progress and to identify new ways to treat it. By joining, you help researchers understand and improve treatment for this condition.
Hear when a new Primary Lymphedema trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.